Double Down

REVIEW SUMMARY
Company. BioVest International Inc.
Industry. Biotechnology
Key. Focusing on processes in product development to guarantee FDA approval.

It takes a great deal of patience, some faith and bit of madness to hold equity in pharmaceutical companies. Things are especially risky for a small biotechnology company that went bankrupt before it could bring its product to the market.

It can take decades to go through the required testing to gain regulatory approval by the Food and Drug Administration, and BioVest International Inc., a Tampa biotechnology firm developing a vaccine for non-Hodgkin's lymphoma, entered Chapter 11 bankruptcy in 2008 in the midst of trials for its vaccine.